Completed OBSERVATIONAL NCT05109065

Peripheral Immune System in Individuals With Schizophrenia

Sponsor: Stanford University

Conditions Schizo Affective Disorder Schizophrenia Schizophreniform Disorders

Interventions Blood Work COVID Screening PQ-B PSS (Perceived Stress Score) Positive and Negative Syndrome Scale (PANSS) SCID (Standardized Clinical Interview for DSM-V) Urine Toxicology Screen Vitals

Updated 7 times since 2021 Last updated: Jun 3, 2025 Started: Mar 1, 2021 Primary completion: May 23, 2024 Completion: May 23, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05109065, this observational or N/A phase trial focuses on Schizo Affective Disorder and Schizophrenia and remains completed. Sponsored by Stanford University, it has been updated 7 times since 2021, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Jul 2025 — Present [monthly]

Completed

Status: Recruiting → Completed
Sep 2024 — Jul 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting
May 2023 — Apr 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2022 — May 2023 [monthly]

Recruiting
Dec 2021 — Apr 2022 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States